Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

PURPOSE: Increased circulating tumor cells (CTCs; five or more CTCs per 7.5 mL of whole blood) are associated with poor prognosis in metastatic breast cancer (MBC). A randomized trial of patients with persistent increase in CTCs tested whether changing chemotherapy after one cycle of first-line chem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smerage, Jeffrey B., Barlow, William E., Hortobagyi, Gabriel N., Winer, Eric P., Leyland-Jones, Brian, Srkalovic, Gordan, Tejwani, Sheela, Schott, Anne F., O'Rourke, Mark A., Lew, Danika L., Doyle, Gerald V., Gralow, Julie R., Livingston, Robert B., Hayes, Daniel F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2014
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209100/
https://ncbi.nlm.nih.gov/pubmed/24888818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.2561
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars